Metabolic & Weight-Management Research
Energy partitioning, glucose handling, and body-composition compounds. The most actively researched class as of 2026.
-
01·01Retatrutide
Triple-agonist analog · GLP-1 / GIP / glucagon
10 mg ≥99% HPLCRetatrutide-class triple-receptor agonist in active clinical investigation.
Add to cart -
01·025-Amino-1MQ
NNMT inhibitor · small molecule
50 mg ≥99% HPLCSelective inhibitor of nicotinamide N-methyltransferase. Oral-bioavailable.
Add to cart -
01·03MOTS-c
Mitochondrial-derived peptide
10 mg ≥99% HPLC16‑residue peptide encoded by mitochondrial DNA — studied for insulin sensitivity.
Add to cart
Recovery & Tissue Repair Research
Angiogenic and cytoprotective compounds — the most-studied class in the research-peptide literature.
-
02·01BPC-157
Pentadecapeptide
10 mg ≥99% HPLC15‑amino‑acid sequence derived from human gastric juice protein. Angiogenic.
Add to cart -
02·02TB-500
Thymosin β4 fragment
10 mg ≥98% HPLCDrives cell migration to injury sites and supports microvasculature formation.
Add to cart -
02·03GHK-Cu
Copper tripeptide
50 mg ≥99% HPLCThree amino acids bound to a copper ion. Modulates expression of thousands of genes.
Add to cart
GH & Performance Research
Peptides acting at distinct nodes of the somatotropic axis — hypothalamic GHRH through hepatic IGF-1.
-
03·01CJC-1295 / Ipamorelin
GHRH analog · GHRP blend
10 mg ≥99% HPLCPaired GHRH/GHRP stimulation of endogenous GH release — the foundation stack.
Add to cart -
03·02Tesamorelin
GHRH analog
10 mg ≥99% HPLCStabilized GHRH analog studied for visceral adiposity in clinical trial literature.
Add to cart -
03·03IGF-1 LR3
IGF-1 analog · long-arginine 3
1 mg ≥99% HPLCLong-acting IGF-1 analog with extended half-life and reduced binding-protein affinity.
Add to cart
Cellular & Longevity Research
Broad cellular-maintenance compounds — coenzymes, substrates of the sirtuin / NAD axis, and multi-pathway peptides.
-
04·01NAD+
Coenzyme · nicotinamide adenine dinucleotide
100 mg ≥99% HPLCCentral redox cofactor and substrate for sirtuins, PARPs, and CD38.
Add to cart -
04·02
MOTS-c
Mitochondrial-derived peptide
10 mg ≥99% HPLC16‑residue peptide encoded by mitochondrial DNA — studied for insulin sensitivity.
Add to cart -
04·03
GHK-Cu
Copper tripeptide
50 mg ≥99% HPLCThree amino acids bound to a copper ion. Modulates expression of thousands of genes.
Add to cart
Blends Research
Multi-peptide blends combining complementary mechanisms in a single vial.
Stack Research
Curated multi-vial protocols — each stack targets a specific research axis.
-
06·01
Adiposity & Metabolic Signaling Research
Retatrutide · 5-Amino-1MQ · MOTS-c · Tesamorelin
4 vials ProtocolMulti-pathway metabolic protocol covering incretin, NNMT, mitochondrial, and GH axes.
Add stack -
06·02
GH Secretagogue & Lean Mass Research
Tesamorelin · CJC-1295 no DAC · Ipamorelin · IGF-1 LR3
3 vials ProtocolLayered GHRH/GHRP and IGF-axis signaling for lean-mass research.
Add stack -
06·03
Recovery & Connective Tissue Research
CJC-1295 no DAC · Ipamorelin · TB-500 · BPC-157
4 vials ProtocolPerformance recovery protocol pairing GH secretagogues with tissue-repair peptides.
Add stack -
06·04
Tissue Remodeling & Cellular Repair Research
BPC-157 · TB-500 · GHK-Cu
3 vials ProtocolThree-compound connective-tissue protocol — angiogenic, migratory, and matrix-remodeling.
Add stack -
06·05
Mitochondrial & Cellular Longevity Research
GHK-Cu · MOTS-c · 5-Amino-1MQ · NAD+
4 vials ProtocolLongevity-axis protocol targeting NAD metabolism, mitochondrial signaling, and cellular repair.
Add stack -
06·06
Glucose Regulation & Metabolic Pathway Research
Retatrutide · MOTS-c · 5-Amino-1MQ · BPC-157
4 vials ProtocolGlucose-handling protocol spanning incretin, mitochondrial, NNMT, and cytoprotective pathways.
Add stack
Focused protocols. Verified listings. Built for laboratory research.
Research use only · For laboratory research